Newsroom » Experts
Download image: Brian Thomas
bft rti.org
919-541-6552

Brian F. Thomas

Director, Analytical Chemistry and Pharmaceutics

Brian F. Thomas, PhD, has more than 20 years of experience in analytical chemistry and mass spectrometry (MS). He is the principal investigator/co-principal investigator on two National Institute on Drug Abuse repository and purity specification contracts. He also holds an R01 grant with the National Institutes of Health. His principal duties include overseeing the development of chromatographic assays (gas chromatography [GC], high-performance liquid chromatography [HPLC], GC/MS, HPLC/MS) and spectrophotometric assays for the qualitative and quantitative analysis of bulk chemicals or chemicals in dosage formulations, biological fluids, tissues, or other complex matrices. Dr. Thomas was recently awarded RTI’s President’s Award for his scientific contributions to the institute.

Education

PhD, Pharmacology, Virginia Commonwealth University; BA, Biology, Kenyon College.

Publications

Analytical surveillance of emerging drugs of abuse and drug formulations — Life Sciences
Thomas, B.F., Pollard, G.T., & Grabenauer, M. (Mar 2013)
Advanced analytical techniques
Kwong, T.C., Magnani, B., Rosano, T.G. & Shaw, L.M. (Eds.) (Jan 2013)
Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice — European Journal of Pharmacology
Wiley, J.L., Marusich, J.A., Zhang, Y., Fulp, A., Maitra, R., Thomas, B.F., et al. (Nov 2012)
Spermicidal and/or antifungal composition and methods of using the same
Cook, C.E., Sloan, C.D., Thomas, B.F., & Navarro, H.A. (Jun 2012)
Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: Implications for nontargeted screening of designer drugs — Analytical Chemistry
Grabenauer, M., Krol, W.L., Wiley, J.L., & Thomas, B.F. (Jun 2012)
View all publications by Brian F. Thomas

Expertise

News